Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 30 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Φίλτρα: Συντάκτης is Dardiotis, Efthimios  [Clear All Filters]
Journal Article
Doulberis, M., Kotronis G., Gialamprinou D., Özgüler O., Exadaktylos A. K., Oikonomou V., et al. (2019).  Acute Liver Failure: From Textbook to Emergency Room and Intensive Care Unit With Concomitant Established and Modern Novel Therapies.. J Clin Gastroenterol. 53(2), 89-101.
Dardiotis, E., Paterakis K., Tsivgoulis G., Tsintou M., Hadjigeorgiou G. F., Dardioti M., et al. (2014).  AQP4 tag single nucleotide polymorphisms in patients with traumatic brain injury.. J Neurotrauma. 31(23), 1920-6.
Kara, E., Xiromerisiou G., Spanaki C., Bozi M., Koutsis G., Panas M., et al. (2014).  Assessment of Parkinson's disease risk loci in Greece.. Neurobiol Aging. 35(2), 442.e9-442.e16.
Ross, O. A., Soto-Ortolaza A. I., Heckman M. G., Aasly J. O., Abahuni N., Annesi G., et al. (2011).  Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study.. Lancet Neurol. 10(10), 898-908.
Andravizou, A., Dardiotis E., Artemiadis A., Sokratous M., Siokas V., Tsouris Z., et al. (2019).  Brain atrophy in multiple sclerosis: mechanisms, clinical relevance and treatment options.. Auto Immun Highlights. 10(1), 7.
Kountouras, J., Polyzos S. A., Katsinelos P., Zeglinas C., Artemaki F., Tzivras D., et al. (2017).  Cardio-cerebrovascular disease and Helicobacter pylori-related metabolic syndrome: We consider eradication therapy as a potential cardio-cerebrovascular prevention strategy.. Int J Cardiol. 229, 17-18.
Zacharaki, D., Lagoudaki R., Touloumi O., Kotta K., Voultsiadou A., Poulatsidou K-N., et al. (2013).  Characterization of in vitro expanded bone marrow-derived mesenchymal stem cells isolated from experimental autoimmune encephalomyelitis mice.. J Mol Neurosci. 51(2), 282-97.
Andravizou, A., Siokas V., Artemiadis A., Bakirtzis C., Aloizou A-M., Grigoriadis N., et al. (2020).  Clinically reliable cognitive decline in relapsing remitting multiple sclerosis: Is it the tip of the iceberg?. Neurol Res. 42(7), 575-586.
Vilou, I., Bakirtzis C., Artemiadis A., Ioannidis P., Papadimitriou M., Konstantinopoulou E., et al. (2020).  Computerized cognitive rehabilitation for treatment of cognitive impairment in multiple sclerosis: an explorative study.. J Integr Neurosci. 19(2), 341-347.
Theotokis, P., Kleopa K. A., Touloumi O., Lagoudaki R., Lourbopoulos A., Nousiopoulou E., et al. (2015).  Connexin43 and connexin47 alterations after neural precursor cells transplantation in experimental autoimmune encephalomyelitis.. Glia. 63(10), 1772-83.
Hadjigeorgiou, G., Dardiotis E., Tsivgoulis G., Doskas T., Petrou D., Makris N., et al. (2015).  Correction: Observational study assessing demographic, economic and clinical factors associated with access and utilization of health care services of patients with multiple sclerosis under treatment with interferon beta-1b (EXTAVIA).. PLoS One. 10(10), e0140308.
Sokratous, M., Dardiotis E., Bellou E., Tsouris Z., Michalopoulou A., Dardioti M., et al. (2018).  CpG Island Methylation Patterns in Relapsing-Remitting Multiple Sclerosis.. J Mol Neurosci. 64(3), 478-484.
Dardiotis, E., Paterakis K., Siokas V., Tsivgoulis G., Dardioti M., Grigoriadis S., et al. (2015).  Effect of angiotensin-converting enzyme tag single nucleotide polymorphisms on the outcome of patients with traumatic brain injury.. Pharmacogenet Genomics. 25(10), 485-90.
Tsivgoulis, G., Katsanos A. H., Grigoriadis N., Hadjigeorgiou G. M., Heliopoulos I., Papathanasopoulos P., et al. (2015).  The effect of disease-modifying therapies on brain atrophy in patients with clinically isolated syndrome: a systematic review and meta-analysis.. Ther Adv Neurol Disord. 8(5), 193-202.
Dardiotis, E., Panayiotou E., Provatas A., Christodoulou K., Hadjisavvas A., Antoniades A., et al. (2017).  Gene variants of adhesion molecules act as modifiers of disease severity in MS.. Neurol Neuroimmunol Neuroinflamm. 4(4), e350.
Dardiotis, E., Panayiotou E., Siokas V., Aloizou A-M., Christodoulou K., Hadjisavvas A., et al. (2019).  Gene variants of adhesion molecules predispose to MS: A case-control study.. Neurol Genet. 5(1), e304.
Pavlidou, E., Daponte A., Egea R., Dardiotis E., Hadjigeorgiou G. M., Barbadilla A., et al. (2016).  Genetic polymorphisms of FAS and EVER genes in a Greek population and their susceptibility to cervical cancer: a case control study.. BMC Cancer. 16(1), 923.
Kountouras, J., Polyzos S. A., Katsinelos P., Zeglinas C., Artemaki F., Tzivras D., et al. (2017).  Helicobacter pylori eradication to prevent cardio-cerebrovascular disease: Are current data useful for clinical practice?. Int J Cardiol. 233, 92.
Kountouras, J., Doulberis M., Polyzos S. A., Zeglinas C., Vardaka E., Kountouras C., et al. (2018).  Helicobacter pylori Infection and Gastroesophageal Reflux Disease-Barrett's Esophagus-Esophageal Adenocarcinoma Sequence.. Am J Gastroenterol. 113(11), 1723-1724.
Kountouras, J., Boziki M., Polyzos S. A., Katsinelos P., Gavalas E., Zeglinas C., et al. (2017).  Impact of reactive oxygen species generation on Helicobacter pylori-related extragastric diseases: a hypothesis.. Free Radic Res. 51(1), 73-79.
Dardiotis, E., Siokas V., Zafeiridis T., Paterakis K., Tsivgoulis G., Dardioti M., et al. (2017).  Integrins AV and B8 Gene Polymorphisms and Risk for Intracerebral Hemorrhage in Greek and Polish Populations.. Neuromolecular Med. 19(1), 69-80.
Grammatikopoulou, M. G., Tousinas G., Balodimou C., Anastasilakis D. A., Gkiouras K., Dardiotis E., et al. (2022).  Ketogenic therapy for Parkinson's disease: A systematic review and synthesis without meta-analysis of animal and human trials.. Maturitas. 163, 46-61.
Tsatsakis, A., Docea A. Oana, Calina D., Tsarouhas K., Zamfira L-M., Mitrut R., et al. (2019).  A Mechanistic and Pathophysiological Approach for Stroke Associated with Drugs of Abuse.. J Clin Med. 8(9), 
Siokas, V., Tsouris Z., Aloizou A-M., Bakirtzis C., Liampas I., Koutsis G., et al. (2020).  Multiple Sclerosis: Shall We Target CD33?. Genes (Basel). 11(11), 
Hadjigeorgiou, G., Dardiotis E., Tsivgoulis G., Doskas T., Petrou D., Makris N., et al. (2014).  Observational study assessing demographic, economic and clinical factors associated with access and utilization of health care services of patients with multiple sclerosis under treatment with interferon beta-1b (EXTAVIA).. PLoS One. 9(11), e113933.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.